Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 2014 Nov;104(11):2057–2059. doi: 10.2105/AJPH.2014.302111

Wounds on Wheels: Implementing a Specialized Wound Clinic within an Established Syringe Exchange Program in Baltimore, Maryland

Natanya Robinowitz 1,, Maria Elisa Smith 1, Chris Serio-Chapman 1, Patrick Chaulk 1, Kristine E Johnson 1
PMCID: PMC4202967  PMID: 25211723

Abstract

People who inject drugs (PWID) experience a high incidence of abscesses and chronic wounds. However, many PWID delay seeking care for their wounds. In 2012, the Baltimore Needle Exchange Program (BNEP) in Baltimore, Maryland, partnered with the Johns Hopkins Wound Healing Center to establish a mobile BNEP Wound Clinic. This clinic provided specialized wound care for BNEP patients. In sixteen months, the clinic treated 78 unique patients during 172 visits overall. On average, each visit cost the program $146.45, which was substantially less than clinic-based treatment. This program demonstrates that specialized wound care can be effectively provided through mobile outreach. A community-based service delivery approach might serve as a model for local health departments looking to improve the health of PWID.


Injection-Related Wounds, including abscesses and chronic ulcers, are major causes of morbidity for people who inject drugs (PWID).1 Previous studies describe wound prevalence in the PWID population to be between 29% and 36%2 and prevalence of injection-related skin infection history to be between 55% and 68%.3,4 Left untreated, injection-related wounds may lead to more severe complications such as sepsis, gangrene, or endocarditis.1 Additionally, chronic wounds are costly to the health care system. Venous leg ulcers, a common cause of chronic wounds among PWID, have an average monthly treatment cost of $4095.5

Compared with non–drug-using populations, PWID have disproportionately high rates of emergency department utilization and are less likely to receive care for their medical conditions.6 Health clinics using harm-reduction models appear cost-effective and can improve health outcomes by minimizing barriers to care.7,8 Additionally, syringe exchange programs often refer PWID to a variety of heath services.8

The Baltimore, Maryland, metropolitan area has an estimated 40 000 PWID.9 Since 1994, the Baltimore City Health Department has operated the Baltimore Needle Exchange Program (BNEP) out of converted recreational vehicles (RVs). BNEP travels to fixed sites across the city and provides clean needles and injection tools to PWID. BNEP also offers overdose prevention training, immunizations, and reproductive health services. These programs have been shown to have lower costs and be successful in providing care to marginalized populations.10,11

BACKGROUND AND PROGRAM DESIGN

Since the BNEP’s inception, staff reported high rates of abscesses and other chronic wounds. Clients were given basic wound-care kits and advised to seek medical care, but high rates of wounds persisted. To address this need, the BNEP partnered with infectious disease physicians from the Johns Hopkins Wound Healing Center to open a mobile wound clinic on BNEP RVs. It was hypothesized that by placing a specialized wound clinic within an established community program, barriers such as costs, transportation, and stigma could be overcome, and patients could receive high-quality wound care.

The Wound Clinic began operations in May 2012, and services were available to any BNEP client experiencing acute or chronic wounds. A physician volunteer with expertise in wounds provided medical care, while BNEP staff managed supplies, outreach, and logistical support.

The Wound Clinic operated twice a week at 2 BNEP shifts (Mondays 9:30–11:30 a.m. and Tuesdays 12:45–3:30 p.m.). The clinic was held in a custom-designed examination room on the RV that included an examination table, a work counter, overhead shelves, and biohazard waste bins (see Appendix A, available as a supplement to the online version of this article at http://www.ajph.org).

The following treatments were performed at the BNEP Wound Clinic:

  • Wound assessment;

  • Wound cleaning;

  • Incision and drainage of acute abscesses;

  • Sharp debridement of chronic ulcers;

  • Compression treatment, including multilayered compression wraps;

  • Prescription and dispensing of antibiotics; and

  • Specialized wound dressing application and dispensing

Basic and specialized wound dressings were used in the clinic and provided for home use. Oral antibiotics were kept on site and dispensed when deemed clinically appropriate by the supervising physician. Patients were asked to return within 1 week for follow-up. All patients were counseled on wound care to minimize skin-associated risk behaviors. Patients with severe chronic wounds who required advanced clinic-based treatment were referred to the Johns Hopkins Wound Healing Center or other local wound centers.

OUTCOMES

Demographics of all patients who received care in the BNEP Wound Clinic are shown in Table 1. There were roughly even numbers of African American and White patients. The mean age was 43.5 years (SD = 11.18), and the median age was 43 years.

TABLE 1—

Demographic Characteristics of Wound Clinic Patients (n = 78): Baltimore, MD, May 2012–August 2013

Characteristics Patients, No. (%)
Sex
 Male 40 (51.3)
 Female 38 (48.7)
Age, y
 18–24 3 (3.7)
 25–34 16 (19.8)
 35–44 26 (32.1)
 45–54 14 (21.0)
 55–64 18 (22.2)
 > 65 1 (1.2)
Race/ethnicity
 Black 30 (40.7)
 White 43 (53.1)

Table 2 shows reasons for visits over the first 16 months of the program. Seventy-eight unique patients were seen across 172 total visits. Of these visits, 116 were chronic wound visits and 52 addressed acute wounds or abscesses. Antibiotics were prescribed and dispensed on 38 occasions.

TABLE 2—

Visit Characteristics at the Wound Clinic: Baltimore, MD, May 2012–August 2013

Visits, No. (%)
All visits 172 (100)
Primary reason for visit
Acute wound or abscess 52 (30.2)
Chronic wound 116 (67.4)
Other concernsb 4 (2.3)
Visits during which antibiotics were prescribed 38 (22.1)
a

Defined as an open area on the skin present for 2 months or longer.

b

Including hematoma, ganglion cyst, and early venous wounds.

COSTS

Costs for the program include supplies and staff salaries. Overhead costs were minimized because the clinic took place alongside current BNEP operations.

Total costs for the first 16 months of the program included wound care supplies ($6854.37) and partial salary for 1 BNEP staff ($18 333.00). These costs averaged to $146.45 per visit. The authors obtained additional Medicare cost data from a local wound center for initial visits. These ranged between $341 and $742 per visit. The program relied on the services of a volunteer physician; therefore, actual costs of the BNEP Wound Clinic cannot be strictly compared with clinic costs.

EVALUATION

The BNEP Wound Clinic demonstrates that specialized wound clinics can be implemented successfully on mobile clinics within an established harm-reduction program. We suggest that these types of programs may be offered at a relatively low cost and can reach populations who otherwise might not receive care for their wounds.

The program was successful in providing care for clients who frequently rely on emergency departments for medical care. Among a population of chronic wound patients, ongoing, routine care is essential to achieve wound healing. To engage clients, the program relied on rapport already established by BNEP. The success of the program has led BNEP to consider expanding its health services for its population to including hepatitis C testing and linkage to care.

Costs were relatively low, given the high cost of specialized wound care, particularly for chronic wounds. Further research is needed to determine the effect of these types of community-based programs on local emergency department admissions and hospitalizations.

Given the lack of space, staff was only able to see 1 patient at a time, which may have affected the number of patients. Another challenge was patient retention. Many patients did not have phones, which made it difficult to establish follow-up. Patients themselves faced numerous challenges in caring for their wounds because some did not have access to clean water or stable housing.

While many PWID-specific health programs address infectious diseases such as HIV and hepatitis C, a need exists for formalized wound care among this population. A growing body of evidence suggests that harm-reduction programs with established relationships with PWID are particularly suited to link their clients with such services.

Acknowledgments

Funding for the study was provided by NIH K23AI083100 and the Baltimore City Health Deparment.

The authors would like to acknowledge the Baltimore City Needle Exchange Program Clients and Study Participants; Baltimore City Health Department and Needle Exchange Program Staff; Jonathan Zenilman, MD; and the Johns Hopkins Bayview Division of Infectious Diseases.

Human Participant Protection

Approval to conduct research with human participants was given by the Johns Hopkins School of Medicine Institutional Review Board, with an authorization agreement with the Baltimore City Health Department.

References

  • 1.Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002;16(3):697. doi: 10.1016/s0891-5520(02)00017-x. [DOI] [PubMed] [Google Scholar]
  • 2.Takahashi TA, Baernstein A, Binswanger I, Bradley K, Merrill JO. Predictors of hospitalization for injection drug users seeking care for soft tissue infections. J Gen Intern Med. 2007;22(3):382–388. doi: 10.1007/s11606-006-0079-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Phillips KT, Stein MD. Risk practices associated with bacterial infections among injection drug users in Denver, Colorado. Am J Drug Alcohol Abuse. 2010;36(2):92–97. doi: 10.3109/00952991003592311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hope V, Marongiu A, Parry J, Ncube F. The extent of injection site infection in injecting drug users: findings from a national surveillance study. Epidemiol Infect. 2010;138(10):1510–1518. doi: 10.1017/S0950268810000324. [DOI] [PubMed] [Google Scholar]
  • 5.Hankin CS, Knispel J, Lopes M, Bronstone A, Maus E. Clinical and cost efficacy of advanced wound care matrices for venous ulcers. J Manag Care Pharm. 2012;18:375–384. doi: 10.18553/jmcp.2012.18.5.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Chitwood DD, McBride DC, French MT, Comerford M. Health care need and utilization: a preliminary comparison of injection drug users, other illicit drug users, and nonusers. Subst Use Misuse. 1999;34(4-5):727–746. doi: 10.3109/10826089909037240. [DOI] [PubMed] [Google Scholar]
  • 7.Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Arch Surg. 2002;137(11):1217. doi: 10.1001/archsurg.137.11.1217. [DOI] [PubMed] [Google Scholar]
  • 8.Islam MM, Topp L, Day CA, Dawson A, Conigrave KM. The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature. Int J Drug Policy. 2012;23(2):94–102. doi: 10.1016/j.drugpo.2011.08.005. [DOI] [PubMed] [Google Scholar]
  • 9.Friedman SR, Tempalski B, Cooper H et al. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users. J Urban Health. 2004;81(3):377–400. doi: 10.1093/jurban/jth125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Moore E, Han J, Serio-Chapman C, Mobley C, Watson C, Terplan M. Contraception and clean needles: feasibility of combining mobile reproductive health and needle exchange services for female exotic dancers. Am J Public Health. 2012;(0):1–4. doi: 10.2105/AJPH.2012.300842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the staying alive programme: Training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20(2):131–136. doi: 10.1016/j.drugpo.2008.03.002. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES